Ronald Kirk Huntsman, Chief Executive Officer at Vivos Therapeutics, Inc. (VVOS), bought 15,021 shares at $0.53 ($8K) on 2023-06-16, disclosed to the SEC on 2023-06-20.
Open-market purchase of $8k VVOS by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.50 | 21 | $11 | 0.1% |
| 2 | $0.53 | 5,000 | $3K | 32.9% |
| 3 | $0.54 | 10,000 | $5K | 67.0% |
| Total | $0.54 avg | 15,021 | $8K | 100% |
| Filing → |
| VVOS | BUY | 2022-12-28 | $10K | — | Filing → |
| VVOS | BUY | 2022-06-03 | $24K | — | Filing → |
| VVOS | BUY | 2021-09-22 | $22K | — | Filing → |